Pharma L-Aspartic Acid BP/EP Grade from Japan
European Pharmacopoeia (EP) and British Pharmacopoeia (BP) compliant L-aspartic acid for medicinal use. HTS 2922.49.49.15 applies to this chemically defined L-amino acid used in injectables and oral meds. Meets ICH Q7 GMP standards for API manufacturing.
Duty Rate — Japan → United States
23.3%
Rate breakdown
9903.04.6210.8%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• File Drug Master File (DMF) prior to import for FDA-regulated pharma entries
• Include EP/BP monograph compliance cert; microbial limits critical for sterile use
• Validate chiral purity via polarimetry to distinguish from racemic mixtures